MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202618084805 A) filed by Boehringer Ingelheim Rcv Gmbh & Co Kg; Validogen Gmbh; and Lonza Ltd. on July 10, 2026, for “recombinant Host Cell Engineered To Overexpress Helper Proteins”.
Inventors include Gasser, Brigitte; Mattanovich, Diethard; and Buchetics, Markus.
The application for the patent was published on September 04, 2026, under issue no. 36/2026.
Abstract: ABSTRACT “RECOMBINANT HOST CELL ENGINEERED TO OVEREXPRESS HELPER PROTEINS” The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.
Disclaimer: Curated by HT Syndication.
